Acrivon Therapeutics (ACRV) Stock Chart & Stock Price History $6.55 +0.11 (+1.71%) (As of 11/22/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Acrivon Therapeutics Stock Price Performance 5 Day Performance+4.47%1 Month Performance-18.73%3 Month Performance-30.02%6 Month Performance-19.24%Year-To-Date Performance+33.13%1 Year Performance+79.45% Receive ACRV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Acrivon Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 2025: Digital Asset Insights You Need to Know (Ad)Cryptocurrencies are taking off again, and those in-the-know are positioning themselves to ride this wave in 2025. The question is—will you be one of them? With explosive growth on the horizon, there’s never been a better time to understand the potential gains in crypto. Our guide, Navigating the Future: Cryptos to Watch in 2025, reveals the cryptos leading this surge and the strategies to maximize your profit potential.Get your guide today! ACRV Stock Chart for Saturday, November, 23, 2024 ACRV Chart by TradingView Acrivon Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/22/2024$6.44$6.55+1.71%$6.63$6.3325,934 shs$203.97 million11/21/2024$6.50$6.44-0.92%$6.68$6.4327,283 shs$200.54 million11/20/2024$6.38$6.50+1.88%$6.66$6.3231,156 shs$202.38 million11/19/2024$6.27$6.38+1.75%$6.49$6.1146,427 shs$198.67 million11/18/2024$6.96$6.27-9.91%$6.98$6.2571,232 shs$195.25 million11/15/2024$7.92$6.96-12.12%$8.35$6.89113,482 shs$215.55 million Get the Latest News and Ratings for ACRV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Acrivon Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/14/2024$7.93$7.92-0.13%$8.13$7.8140,037 shs$245.28 million11/13/2024$8.39$7.93-5.48%$8.54$7.9376,383 shs$245.59 million11/12/2024$8.23$8.39+1.94%$8.46$8.0253,760 shs$259.84 million11/11/2024$8.57$8.23-3.97%$8.66$8.1526,143 shs$254.90 million11/08/2024$8.50$8.57+0.82%$8.61$8.3833,422 shs$265.43 million11/07/2024$8.37$8.50+1.55%$8.74$8.2180,294 shs$263.25 million11/06/2024$7.83$8.37+6.90%$8.49$8.0071,687 shs$259.22 million11/05/2024$7.85$7.83-0.25%$7.89$7.6927,865 shs$242.50 million11/04/2024$8.01$7.85-2.00%$8.05$7.8035,765 shs$243.13 million11/01/2024$8.00$8.01+0.12%$8.13$7.9235,926 shs$248.07 million10/31/2024$8.35$8.00-4.19%$8.33$7.9836,018 shs$247.78 million10/30/2024$8.27$8.35+0.97%$8.46$8.1626,495 shs$257.82 million10/29/2024$8.17$8.27+1.22%$8.30$8.0929,890 shs$255.35 million10/28/2024$7.96$8.17+2.64%$8.25$7.9549,496 shs$252.27 million10/25/2024$8.03$7.96-0.87%$8.03$7.9340,448 shs$245.78 million10/24/2024$8.06$8.03-0.37%$8.16$7.9527,869 shs$247.94 million10/23/2024$8.05$8.06+0.12%$8.11$7.9074,843 shs$248.87 million10/22/2024$8.05$8.05$8.24$7.9749,902 shs$248.56 million Related Companies Cronos Group Stock Chart Pliant Therapeutics Stock Chart Kura Oncology Stock Chart Tyra Biosciences Stock Chart Prothena Stock Chart Relay Therapeutics Stock Chart Anavex Life Sciences Stock Chart Replimune Group Stock Chart Autolus Therapeutics Stock Chart Erasca Stock Chart Receive ACRV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Acrivon Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ACRV) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acrivon Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acrivon Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
